2024 annual financial data
Immunome 2024 Operating margin
Immunome 2024 operating margin with verified reported values.
Direct answer
Operating margin was -3,382.37%.
Operating income was -305,800,000 USD and net income was -292,963,000 USD.
Operating cash flow was -110,794,000 USD.
Get free Immunome email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,041,000 USD
- Operating income
- -305,800,000 USD
- Net income
- -292,963,000 USD
- Operating cash flow
- -110,794,000 USD